CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.3350
+0.0070 (2.13%)
May 8, 2025, 3:59 PM EDT
CytoDyn Employees
CytoDyn had 9 employees as of May 31, 2024. The number of employees decreased by 3 or -25.00% compared to the previous year.
Employees
9
Change (1Y)
-3
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$951,667
Market Cap
417.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
CytoDyn News
- 2 days ago - CytoDyn appoints Robert Hoffman as CFO - Seeking Alpha
- 2 days ago - CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - Benzinga
- 2 days ago - CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - GlobeNewsWire
- 9 days ago - CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany - GlobeNewsWire
- 7 weeks ago - March 2025 Letter to Shareholders - GlobeNewsWire
- 2 months ago - CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab - GlobeNewsWire
- 3 months ago - CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories - GlobeNewsWire
- 5 months ago - December 2024 Letter to Shareholders - GlobeNewsWire